Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exatecan mesylate in metastatic breast cancer
NCT00004046Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 1999
- Primary completion
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exatecan in breast cancer, sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 1999; status: completed.
02
Drugs
exatecan
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00004046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004046.